Delivery Order SPE2DE24D0013-SPE2D625F3EQD
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. Issued on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order (XPRS4PLEX-10) carries no set-aside designation and represents a short-term procurement under one of Cepheid's existing indefinite delivery vehicle contracts. The place of performance is Sunnyvale,...
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- The Defense Logistics Agency awarded a delivery order to Cepheid Inc. valued at $26,312.70 under a firm fixed-price contract with an ultimate completion date of August 12, 2025. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing. This delivery order carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $6,390 on September 9, 2025, by the Defense Department's Medical Supply Chain office. The delivery order, designated XPRS4PLEX-10, has an ultimate completion date of September 16, 2025, and involves performance at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents a discrete procurement action under the company's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a $6,800 firm fixed-price delivery order (XPRS4PLEX-10) from the Defense Department's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 29, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies and test kits to federal defense and healthcare systems. This...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $4,568.25 to Cepheid Inc. on August 25, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit manufacturer of molecular diagnostic solutions specializing in advanced diagnostic systems and test kits for...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, has been awarded a delivery order valued at $2,040 under contract XPRS4PLEX-10 by the Medical Supply Chain, a defense-focused federal agency. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, carries no set-aside designation. The work will be performed in Sunnyvale, California, and represents a continuation of Cepheid's ongoing...
- The Defense Department's Medical Supply Chain awarded a $16.2K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 27, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the Department's procurement of diagnostic testing capabilities through Cepheid's established federal contracting vehicles. Cepheid specializes in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3EQDDelivery Order
The Defense Logistics Agency has awarded a $13.6K delivery order (XPRS4PLEX-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities. The award carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. Cepheid specializes in advanced molecular diagnostic systems and test kits, particularly for detecting infectious diseases including COVID-19, influenza, RSV, and other clinical conditions. This delivery order likely falls under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs, which represent the company's primary federal procurement vehicles for diagnostic solutions. Cepheid maintains two significant VA IDV contracts valued at $32.8M and $2.5M respectively, both structured as firm fixed-price delivery order vehicles that enable continuous procurement of molecular diagnostic testing systems, reagents, and assays through 2030. The company's federal contract portfolio reflects its established position as a primary supplier of molecular diagnostics across multiple federal healthcare systems, supporting the government's ongoing need for rapid and accurate infectious disease testing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 9/11/25 |